ELOX
Eloxx Pharmaceuticals, Inc.
13.90$
+1.1%
vs. previous close
Closing price · As of: Oct 12, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -25.0% | +0.0% | – | – | – | – | – | – | – | – | -100.0% | |
| – | – | -47.3% | -58.2% | +453.8% | +158.8% | +2.1% | +68.1% | -27.6% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +36.8% | -54.3% | +684.7% | +24.9% | +26.1% | -43.5% | +56.9% | +3.6% | -63.8% | -58.4% | -14.6% | |
| – | – | – | – | – | – | – | – | – | -18.7% | -39.6% | -35.6% | |
| – | +13.3% | -51.1% | +450.7% | +129.7% | +6.9% | -42.3% | +43.4% | -18.5% | -48.7% | -48.9% | -27.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -96.8% | – | – | -99.0% | +22,985.7% | -12.8% | -10.6% | +54.8% | -40.9% | -0.6% | -8.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.